Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 579 Records) |
Query Trace: Neoplasms and HLA-C[original query] |
---|
Interactions between Polygenetic Variants and Lifestyle Factors in Hypothyroidism: A Hospital-Based Cohort Study. Nutrients 2023 9 15 (17): . Da Sol Kim, Sunmin Pa |
Invasive Breast Cancer: miR-24-2 Targets Genes Associated with Survival and Sensitizes MDA-MB-231 Cells to Berberine. Omics : a journal of integrative biology 2023 9 . Mansoor Ali, Rameshwar N K Bamezai, Rana P Sin |
Association of HLA-G 3' untranslated region indel polymorphism and its serum expression with susceptibility to colorectal cancer. Biomarkers in medicine 2023 9 . Garrach Behaeddin, Ben Othmen Abdelwaheb, Khamlaoui Wided, Yatouji Sonia, Toumi Iheb, Zaied Sonia, Zouari Khadija, Hammami Mohamed, Hammami Son |
Contribution of an Asian-prevalent HLA haplotype to the risk of HBV-related hepatocellular carcinoma. Scientific reports 2023 8 13 (1): 12944. Atsushi Kawamura, Koichi Matsuda, Yoshinori Murakami, Masayuki Saruta, Takashi Kohno, Kouya Shirais |
Analysis of somatic mutations and key driving factors of cervical cancer progression. Open medicine (Warsaw, Poland) 2023 8 18 (1): 20230759. Mayinuer Niyazi, Lili Han, Sulaiya Husaiyin, Ayimila Aishanjiang, Min Guo, Gulibanu Muhaimati, Hankez Rozi, Haiyan Sun, Jing Lu, Chunhua Ma, Nuermangul Rouzi, Xiaowan Liu, Kaichun Z |
Autoimmune HLA Alleles and Neoepitope Presentation Predict Post-Allogenic Transplant Relapse. Journal of immunotherapy and precision oncology 2023 8 6 (3): 127-132. Andrea Castro, Aaron M Goodman, Zachary Rane, James V Talwar, Garrett M Frampton, Gerald P Morris, Scott M Lippman, Xinlian Zhang, Razelle Kurzrock, Hannah Cart |
HLA-G 14 bp Ins/Del (rs66554220) Variant Is Not Associated with Breast Cancer in Women from Western Mexico. Current issues in molecular biology 2023 8 45 (8): 6842-6850. Denisse Stephania Becerra-Loaiza, Luisa Fernanda Roldan Flores, Luis Antonio Ochoa-Ramírez, Bricia M Gutiérrez-Zepeda, Alicia Del Toro-Arreola, Ramón Antonio Franco-Topete, Andrés Morán-Mendoza, Antonio Oceguera-Villanueva, Antonio Topete, David Javalera, Antonio Quintero-Ramos, Adrián Daneri-Navar |
The genetic variant rs55986091 HLA-DQB1 is associated with a protective effect against cervical cancer. Frontiers in oncology 2023 8 13 1207935. Michael A Vinokurov, Konstantin O Mironov, Elvira A Domonova, Tatiana N Romanyuk, Anna A Popova, Vasiliy G Akimk |
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification. Nature communications 2023 8 14 (1): 4632. Celina Tretter, Niklas de Andrade Krätzig, Matteo Pecoraro, Sebastian Lange, Philipp Seifert, Clara von Frankenberg, Johannes Untch, Gabriela Zuleger, Mathias Wilhelm, Daniel P Zolg, Florian S Dreyer, Eva Bräunlein, Thomas Engleitner, Sebastian Uhrig, Melanie Boxberg, Katja Steiger, Julia Slotta-Huspenina, Sebastian Ochsenreither, Nikolas von Bubnoff, Sebastian Bauer, Melanie Boerries, Philipp J Jost, Kristina Schenck, Iska Dresing, Florian Bassermann, Helmut Friess, Daniel Reim, Konrad Grützmann, Katrin Pfütze, Barbara Klink, Evelin Schröck, Bernhard Haller, Bernhard Kuster, Matthias Mann, Wilko Weichert, Stefan Fröhling, Roland Rad, Michael Hiltensperger, Angela M Krackhar |
BRAF, TERT and HLA-G Status in the Papillary Thyroid Carcinoma: A Clinicopathological Association Study. International journal of molecular sciences 2023 8 24 (15): . Bruna C Bertol, Juliana D Massaro, Guilherme Debortoli, André L P Santos, Jéssica N G de Araújo, Tatiana M V Giorgenon, Matheus Costa E Silva, Nathalie L de Figueiredo-Feitosa, Cristhianna V A Collares, Luiz Carlos C de Freitas, Edson G Soares, Luciano Neder, Vivian N Silbiger, Rodrigo T Calado, Léa M Z Maciel, Eduardo A Dona |
Polymorphisms of Killer Ig-like Receptors and the Risk of Glioblastoma. Journal of clinical medicine 2023 7 12 (14): . Haeyoun Choi, In-Cheol Baek, Soon A Park, Jae-Sung Park, Sin-Soo Jeun, Tai-Gyu Kim, Stephen A |
Durable response of lung carcinoma patients to EGFR tyrosine kinase inhibitors is determined by germline polymorphisms in some immune-related genes. Molecular cancer 2023 7 22 (1): 120. Lorraine Dalens, Julie Niogret, Corentin Richard, Sandy Chevrier, Pascal Foucher, Bruno Coudert, Aurélie Lagrange, Laure Favier, Virginie Westeel, Stefano Kim, Olivier Adotevi, Caroline Chapusot, Laurent Martin, Laurent Arnould, Courèche-Guillaume Kaderbhai, Romain Boid |
Association of two genomic variants with HPV type-specific risk of cervical cancer. Tumour virus research 2023 7 16 200269. Finja Seifert, Rieke Eisenblätter, Julia Beckmann, Peter Schürmann, Patricia Hanel, Matthias Jentschke, Gerd Böhmer, Hans-Georg Strauß, Christine Hirchenhain, Monika Schmidmayr, Florian Müller, Peter Fasching, Alexander Luyten, Norman Häfner, Matthias Dürst, Ingo B Runnebaum, Peter Hillemanns, Thilo Dörk, Dhanya Ramachandr |
Associations of HLA-C*01:02 and HLA-B*46:01 with regorafenib-induced erythema multiforme in Japanese patients with metastatic colorectal cancer. Clinical and translational science 2023 7 . Ken-Ichi Fujita, Natsumi Matsumoto, Remi Murase, Kosuke Takeshima, Hiroo Ishida, Yutaro Kubo |
Association between brain cancer immunogenetic profile and in silico immunogenicities of 11 viruses. Scientific reports 2023 12 13 (1): 21528. Apostolos P Georgopoulos, Lisa M Jam |
Identification of molecular subtypes and a risk model based on inflammation-related genes in patients with low grade glioma. Heliyon 2023 12 9 (12): e22429. Cheng Long, Ya Song, Yimin Pan, Changwu |
Driver mutations in GNAQ and GNA11 genes as potential targets for precision immunotherapy in uveal melanoma patients. Oncoimmunology 2023 12 12 (1): 2261278. Sandra García-Mulero, Roberto Fornelino, Marco Punta, Stefano Lise, Mar Varela, Luis P Del Carpio, Rafael Moreno, Marcel Costa-García, Dietmar Rieder, Zlatko Trajanoski, Alena Gros, Ramón Alemany, Josep María Piulats, Rebeca Sanz-Pamplo |
Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer. Frontiers in immunology 2023 11 14 1268117. Ya-Yu Tsai, Chenxu Qu, Joseph D Bonner, Rebeca Sanz-Pamplona, Sidney S Lindsey, Marilena Melas, Kevin J McDonnell, Gregory E Idos, Christopher P Walker, Kevin K Tsang, Diane M Da Silva, Ferran Moratalla-Navarro, Asaf Maoz, Hedy S Rennert, W Martin Kast, Joel K Greenson, Victor Moreno, Gad Rennert, Stephen B Gruber, Stephanie L Schm |
Integration of exome-seq and mRNA-seq using DawnRank, identified genes involved in innate immunity as drivers of breast cancer in the Indian cohort. PeerJ 2023 10 11 e16033. Snehal Nirgude, Sagar Desai, Vartika Khanchandani, Vidhyavathy Nagarajan, Jayanti Thumsi, Bibha Choudha |
Common and distinct patterns of acquired uniparental disomy and homozygous deletions between lung squamous cell carcinomas and lung adenocarcinoma. Neoplasia (New York, N.Y.) 2023 10 45 100932. Musaffe Tuna, Gordon B Mills, Christopher I Am |
Association of HLA-A*11:01, -A*24:02, and -B*18:01 with Prostate Cancer Risk: A Case-Control Study. International journal of molecular sciences 2023 10 24 (20): . Maria Antonietta Manca, Elena Rita Simula, Davide Cossu, Tatiana Solinas, Massimo Madonia, Roberto Cusano, Leonardo Antonio Sec |
Association of HLA-A, B, and C alleles and cancer susceptibility in 179 solid malignancies. American journal of translational research 2023 10 15 (9): 5642-5652. Miguel Carabaño, Tao Liu, Abraham Liu, Jim ChunHao Lee, Liang Cheng, Li-Juan Wang, Chiung-Kuei Huang, Shaolei |
The Prognostic Significance of Selected HLA Alleles on Prostate Cancer Outcome. International journal of molecular sciences 2023 10 24 (19): . Savvas Stokidis, Constantin N Baxevanis, Sotirios P Fort |
Characterization of cell cycle, inflammation, and oxidative stress signaling role in non-communicable diseases: Insights into genetic variants, microRNAs and pathways. Computers in biology and medicine 2024 4 174 108346. Salvatore D'Antona, Danilo Porro, Francesca Gallivanone, Gloria Berto |
Immunogenetic Diversity and Cancer Immunotherapy Disparities. Cancer discovery 2024 4 14 (4): 585-588. Noel F C C de Miranda, Ferenc A Scheer |
HLA class II polymorphisms as prognostic biomarkers for right and left-sided colon cancer. The International journal of biological markers 2024 1 3936155231224469. Amani Attia, Awatef Lagha, Amel Mezlini, Ezzedine Ghazouani, Besma Yacoubi-Loueslati, Imene Namouc |
Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer. Scientific reports 2024 1 14 (1): 345. Cindy Y Jiang, Lili Zhao, Michael D Green, Shashidhar Ravishankar, Andrea M H Towlerton, Anthony J Scott, Malini Raghavan, Matthew F Cusick, Edus H Warren, Nithya Ramna |
Case Report of a DDX41 Germline Mutation in a Family with Multiple Relatives Suffering from Leukemia. Biomedicines 2024 1 12 (1): . Jan Nicolai Wagner, Maximilian Al-Bazaz, Anika Forstreuter, Mohammad Ibrahim Hammada, Jurek Hille, Dzhoy Papingi, Carsten Bokemeyer, Walter Fiedl |
Analysis of Somatic Mutations in the TCGA-LIHC Whole Exome Sequence to Identify the Neoantigen for Immunotherapy in Hepatocellular Carcinoma. Current issues in molecular biology 2024 1 46 (1): 106-120. Swetha Pulakuntla, Khajamohiddin Syed, Vaddi Damodara Red |
Association of HLA class I and II genes with cervical cancer susceptibility in a Han Chinese population. HLA 2024 1 103 (1): e15340. Yueting Yao, Zhiling Yan, Chuanyin Li, Shao Zhang, Shuyuan Liu, Xinwen Zhang, Lei Shi, Weipeng Liu, Li Shi, Yufeng Y |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: